SEC Form 4 · accession 0001193125-26-303713
TransMedics Group, Inc. · TMDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nicholas Corcoran
Officer — See remarks
Period of report
Jul 10, 2026
Accepted (ET)
Jul 14, 2026 · 9:37 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001756262
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 10, 2026 | A | 11,727 | $0.00 | A | 41,558 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $71.23 | Jul 10, 2026 | A | 17,784 | A | — | Jul 10, 2036 | Common Stock | 17,784 | 17,784 | D |
Explanation of responses
- F1Consists of 11,727 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- F2The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following April 10, 2026 until the option is fully vested on April 10, 2030, subject to continued service.
Remarks
SVP of Supply Chain and Operations